The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| ITGR | -28.86% | -10.66% | -2.23% | +300% |
| S&P | +21.6% | +71.83% | +11.43% | +372% |
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. It operates through the Medical and Non-Medical segments. The Medical segment includes the cardio and vascular, cardiac and neuromodulation, surgical, orthopedics, and portable medical product lines. The Non-Medical segment comprises customized battery power and management systems, charging and docking stations, and power supplies. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.
Integer Holdings delivers specialized medical devices and battery solutions to major healthcare OEMs worldwide.
Integer Holdings supplies medical device components and finished products to major OEMs in cardiac, neuro, and surgical markets.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $470.90M | 4.2% |
| Gross Profit | $106.10M | -6.9% |
| Gross Margin | 22.53% | -2.7% |
| Market Cap | $2.75B | -38.2% |
| Market Cap / Employee | $249.82K | 0.0% |
| Employees | 11K | 0.0% |
| Net Income | $48.61M | 47.4% |
| EBITDA | $86.62M | -8.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $17.16M | -63.1% |
| Accounts Receivable | $458.63M | 31.4% |
| Inventory | 253.7 | 2.7% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.30B | 19.8% |
| Short Term Debt | $22.11M | -13.9% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 3.17% | -0.9% |
| Return On Invested Capital | 3.74% | 0.0% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $27.94M | -36.7% |
| Operating Free Cash Flow | $55.42M | -12.4% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 55.49 | 54.12 | 42.50 | 27.33 | -30.74% |
| Price to Book | 2.44 | 2.67 | 2.13 | 1.57 | -42.59% |
| Price to Sales | 2.26 | 2.44 | 1.98 | 1.49 | -46.11% |
| Price to Tangible Book Value | -22.39 | -12.93 | -14.40 | -14.41 | -29.62% |
| Price to Free Cash Flow TTM | 35.50 | 36.31 | 29.79 | 26.22 | -45.49% |
| Enterprise Value to EBITDA | 64.89 | 66.77 | 56.17 | 46.83 | -24.45% |
| Free Cash Flow Yield | 2.8% | 2.8% | 3.4% | 3.8% | 83.44% |
| Return on Equity | 5.0% | 5.1% | 5.2% | 6.1% | -20.77% |
| Total Debt | $1.35B | $1.32B | $1.31B | $1.32B | 19.01% |
No podcast episodes available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
